Boston’s innovation economy could add another four public companies this month, with three in biotech and one in tech lined up for initial public offerings. Not yet in the queue is the big one, Wayfair.com.
Tokai Pharmaceuticals and rEVO Biologics could complete their IPOs as soon as this week, according to Renaissance Capital, which tracks the expected US IPO calendar. CyberArk Software and Civitas Therapeutics should go public the following week, Renaissance Capital reports.
The offerings aim to raise a combined $295 million (see the breakdown below).
Wayfair, of course, is seeking to raise more than that all on its own—$350 million, according to the company’s IPO papers. If successful, the home goods site could post the second-largest Boston tech IPO in recent memory (behind A123 Systems).
Wayfair hasn’t been in a hurry to pitch investors in part because of the massive IPO in the works for another e-tailer — Chinese e-commerce giant Alibaba, according to a previous report from the Wall Street Journal. Alibaba is now expected to sell its IPO shares this week, potentially clearing the way for Wayfair to get on deck next.
The one local IPO that closed so far in September is ReWalk Robotics, a builder of wearable robotic exoskeletons for paraplegics, which has an office in Framingham. That gives Massachusetts a tally of 18 IPOs in tech and biotech so far this year, versus 10 in 2013.
As for the IPOs that are ahead this month, here’s the breakdown:
Also check out our past coverage:
Kyle Alspach has worked in journalism in Massachusetts since 2005 and was one of the original staff writers at BetaBoston.
Follow Kyle on Twitter